Medical Research
(H03)
990 on File
INTERNATIONAL SOCIETY FOR TRANSGENIC TECHNOLOGIES INC
Financial strength (30%)
72/100
Reliability (20%)
50/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$89K
Total Revenue
$79K
Total Expenses
$84K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
12.72x
Liability-to-Asset
0.0%
Revenue Diversification
14.1%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 75.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
12.7 mo | 44.2 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
14.1% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-9.6% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-54.8% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.6% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $89K | $79K | $84K | 100.0% | — |
| 2024 | $98K | $175K | $75K | 100.0% | — |
| 2023 | $130K | $42K | $152K | 100.0% | — |
| 2022 | $64K | $125K | $64K | 100.0% | — |
| 2021 | $61K | $47K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.